Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

BioVentrix

Explore full profile

BioVentrix • Less Invasive Ventricular Enhancement.

San Ramon, United StatesFounded 2003Biotech & Life Sciences
Valuation $250–500M Last recorded · 2023
Headcount <100 Current team size
Total funding $100–500M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for BioVentrix and the history behind them.

About BioVentrix

BioVentrix, Inc. is a privately held medical device company based in San Ramon, CA, specializing in developing innovative treatment options for patients suffering from heart failure. The company operates in the medical technology market, focusing on providing minimally invasive solutions to improve patient outcomes and reduce recovery times. BioVentrix's core product, the Revivent System, is designed to treat ischemic heart failure by reshaping the left ventricle of the heart, thereby enhancing its function. The company's primary clients include hospitals, cardiologists, and healthcare providers who seek advanced treatment options for heart failure patients. BioVentrix generates revenue through the sale of its medical devices and related services. The business model is centered around continuous innovation, clinical research, and strategic partnerships to expand its market presence and improve patient care.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2003
Headquarters
San Ramon, United States
Employees
22
Open positions
None listed
Dealroom signal
71.9/100
Industry
Health
Sub-industry
BioTechnology, Medical Devices
Sector
Biotech & Life Sciences, Biotechnology, Non-Invasive medical devices and treatments, Biotech and Pharma, Hard Tech, DT and LS, science-based
Client focus
b2c

Funding history

10 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AOther financing Apr 2023 $49M $194M Richmond Brothers · Cormorant Asset Management · Squarepoint Capital · Taglich Brothers ↗
LATE VCOther financing Dec 2020 $41M $163M Undisclosed —
Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Growth signals

BioVentrix website traffic

Latest recorded traffic for BioVentrix is 1.7K monthly website visits, up 639.1% over the last three months. BioVentrix's team grew 10% over the past year.

Latest monthly visits1.7K 3-month web change+639.1% 1-year team growth+10%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

Team profiled 11 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States85.7%
🇩🇪 Germany14.3%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about BioVentrix on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See BioVentrix’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.